Research programme: hyaluronan mediated motility receptors targeted therapeutics - Novare Pharmaceuticals

Drug Profile

Research programme: hyaluronan mediated motility receptors targeted therapeutics - Novare Pharmaceuticals

Alternative Names: HMMR-protein-target - Novare Pharmaceuticals; Intracellular-hyaluronic-acid-binding-protein-target - Novare Pharmaceuticals; Receptors for hyaluronan mediated motility targeting therapeutics - Novare Pharmaceuticals; RHAMM-binding peptides-Novare Pharmaceuticals; RHAMM-protein-target - Novare Pharmaceuticals

Latest Information Update: 01 Aug 2015

Price : $50

At a glance

  • Originator London Health Sciences Centre Research
  • Developer Novare Pharmaceuticals
  • Class Proteins
  • Mechanism of Action Hyaluronic acid modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Arthritis; Bronchopulmonary dysplasia; Idiopathic pulmonary fibrosis; Keloids; Scars

Most Recent Events

  • 30 Jul 2015 Lawson Health Research Institute has patent protection for composition of matter and use of RHAMM-binding peptides in USA
  • 07 Oct 2014 Novare Pharmaceuticals acquires Receptor for Hyaluronan-Mediated Motility (RHAMM) compounds from London Health Sciences Centre Research
  • 07 Oct 2014 Early research in Arthritis, Breast cancer, Bronchopulmonary dysplasia, Idiopathic pulmonary fibrosis, Keloids and Scars in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top